Reactive, infectious, or post‑infectious arthritis?

Czech version

Authors: Štefan Alušík
Authors‘ workplace: Katedra vnitřního lékařství, IPVZ Praha
Published in: Vnitř Lék 2022; 68(7): 449-453
Category: Review Articles
doi: https://doi.org/10.36290/vnl.2022.094

Overview

The issue of reactive arthritis belongs to one of the most complex problems in rheumatology. Although the original concept of reactive arthritis as a „sterile arthritis“ has already been overcome, much remains unclear. Non-uniform terminology, classification and diagnostic criteria as well as treatment guidelines leave room for different interpretations of this issue. Therefore it is difficult for non-rheumatologists (internal medicine physicians and general practitioners) to find their way around this topic. Our comprehensive report discusses the latest findings from etiology to treatment of reactive arthritis. It also addresses the aforementioned controversies from terminology to the latest list of causative pathogens, including viruses, parasites and vaccines.

Keywords:

diagnosis – treatment – reactive arthritis – post‑infectious arthritis – new causative pathogens

Sources

1. Kuipers JG, Scharmann K, Wollenhaupt J et al. Sensitivities of PCR, MicroTrak, Chlamydia EIA, IDEIA, and PACE 2 for purified Chlamydia trachomatis elementary bodies in urine, peripheral blood, peripheral blood leukocytes, and synovial fluid. J Clin Microbiol. 1995;33(12):3186-90.

2. Kuipers JG, Kohler L, Zeidler H. Reactive or infectious arthritis. Ann Rheum Dis. 1999;58:661-664.

3. Braun J, Kingsley G, van der Heijde D et al. On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3-6, 1999. J Rheumatol. 2000;27(9):2185-92.

4. Bekaryssova, D., Yessirkepov, M., Zimba, O. et al. Reactive arthritis before and after the onset of the COVID-19 pandemic. Clin Rheumatol. 2022; 41(6):1641–1652.

5. Ferreira A, Monteiro M, Vita P et al. al. Post‑infectious arthritis and reactive arthritis. Infection and Autoimmunity.(Second Edit.). Elsevier 2015; 807– 828. Available from: www:https:// doi.org/10.1016/B978-0-444-63269-2.00050-7

6. Morris D, Inman RD. Reactive arthritis: developments and challenges in diagnosis and treatment. Curr Rheumatol Rep. 2012;14(5):390–4.

7. Bojović J, Strelić N, Pavlica L. Reiter’s syndrome-- disease of young men-- analysis of 312 patients. Med Pregl. 2014;67(7-8):222-30

8. Hanova P, Pavelka K, Holcatova I et al. Incidence and prevalence of psoriatic arthritis, ankylosing spondylitis, and reactive arthritis in the first descriptive population‑based study in the Czech Republic. Scand J Rheumatol. 2010;39(4):310-7.

9. Zeidler H, Hudson AP. Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens. Curr Rheumatol Rep. 2021;23(7):53

10. Jubber A, Moorthy A. Reactive arthritis: a clinical review. J R Coll Physicians Edinb. 2021;51(3):288-297.

11. Kobayashi S, Taniguchi Y, Kida I et al. SARS‑CoV2- triggered acute arthritis: Viral arthritis rather than reactive arthritis. J Med Virol. 2021;93(12):6458-6459.

12. Facciolà A, Visalli G, Laganà A et al. An Overview of Vaccine Adjuvants:Current Evidence and Future Perspectives. Vaccines 2022;10, 819. Available from: www: https://doi. org/10.3390/vaccines10050819.

13. Valesová M, Trnavský K, Hulínská D et al. Detection of Borrelia in the synovial tissue from a patient with Lyme borreliosis by electron microscopy. J Rheumatol. 1989;16(11):1502-5.

14. Sharip A, Kunz J. Understanding the Pathogenesis of Spondyloarthritis. Biomolecules. 2020;10(10):1461. Available from: www: https://doi.org/10.3390/biom10101461.

15. Brockett MR, Liechti GW. Persistence Alters the Interaction between Chlamydia trachomatis and Its Host Cell. Infect Immun. 2021;89(8):e0068520. Available from: www: https:// www.ncbi.nlm.nih.gov/pmc/articles/PMC8281235/.

16. Manasson J, Shen N, Ferrer HRG et al. Gut microbiota perturbations in reactive arthritis and post‑infectious spondyloarthritis. Arthritis Rheumatol. 2018;70(2):242-54.

17. Shetty S, Kouskouti C, Schoen U et al. Diagnosis of Chlamydia trachomatis genital infections in the era of genomic medicine. Braz J Microbiol. 2021;52(3):1327-1339.

18. Kebbi‑Beghdadi C, Aeby S, Baud D, Greub G. Evaluation of a Multiplex Real‑Time PCR Assay for Detecting Chlamydia trachomatis in Vaginal Samples. Diagnostics (Basel). 2022;12(5):1141.

19. Carter JD, Espinoza LR, Inman RD et al. Combination antibiotics as a treatment for chronic Chlamydia‑induced reactive arthritis: a double‑blind, placebo‑controlled, prospective trial. Arthritis Rheum. 2010;62(5):1298-307.

20. Barber CE, Kim J, Inman RD et al. Antibiotics for treatment of reactive arthritis: a systematic review and metaanalysis. J Rheumatol. 2013;40(6):916-928.

21. Zeidler H, Hudson AP. Quo vadis reactive arthritis? Curr Opin Rheumatol. 2022;34(4): 218-224.